`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_________________
`
`
`K/S HIMPP,
`
`Petitioner,
`
`v.
`
`III HOLDINGS 4, LLC,
`
`Patent Owner
`_________________
`
`Case IPR2017-00781
`Patent 8,654,999
`_________________
`
`
`Patent Owner’s Reply to Petitioner’s Opposition to
`Patent Owner’s Motion to Exclude
`
`
`
`
`
`I.
`
`
`Introduction
`
`III Holdings 4, LLC (“Patent Owner”) properly objected to and moved for
`
`exclusion of Exhibit 1009, and Petitioner’s Opposition, Paper 21, relies upon
`
`Exhibit 1015 to overcome the objections. However, Exhibit 1015 never addresses
`
`Exhibit 1009, and does not cure the defectively filed declaration of Exhibit 1009.
`
`Since Petitioner fails to cure the deficiencies identified with respect to Exhibit
`
`1009, the Motion to Exclude should be granted. Further, since the Petitioner fails
`
`to provide any argument regarding the admissibility of Exhibits 1011 and 1012, the
`
`Motion with respect to these Exhibits should be granted.
`
`II. The Board Should Exclude Exhibit 1009
`
`Petitioner provides no argument, and effectively concedes, that Exhibit 1009
`
`is improper evidence and should be excluded. Petitioner’s Opposition, Paper 21.
`
`Petitioner provides no argument that Exhibit 1009 should remain part of the record
`
`or that the declaration originally filed with Exhibit 1009 was proper.
`
`Petitioner attempted, but failed, to cure the objections to Exhibit 1009 by
`
`filing Exhibit 1015. The deficiencies identified by the objections timely filed by
`
`Patent Owner remain uncured, and Exhibit 1015 has no effect on the admissibility
`
`of Exhibit 1009. To cure the identified deficiencies, Petitioner needed to provide
`
`evidence that the originally filed translation in Exhibit 1009 was proper. Instead,
`
`Petitioner is improperly attempting to add untimely and unrelated new evidence to
`
`
`
`1
`
`
`
`
`
`this proceeding. Exhibit 1015 never addresses the declaration originally filed in
`
`1009, and provides no insight into accuracy of the originally filed translation.
`
`Exhibit 1015 at 10. Accordingly, Exhibit 1015 is not supplemental evidence
`
`“offered solely to support admissibility of the originally filed evidence” and cannot
`
`be used to defeat the Motion to Exclude. Handi Quilter, Inc. v. Bernina
`
`International AG, Case IPR2013-00364, Paper 30 at 2-3; Rule 42.64(b)(2).
`
`Exhibit 1015 is not “offered solely to support admissibility,” and since
`
`Exhibit 1015 makes no mention of Exhibit 1009, it cannot alleviate the need for the
`
`Board to have to consider whether the initial evidence needs to be excluded. Handi
`
`Quilter, Inc. v. Bernina International AG, Case IPR2013-00364, Paper 30 at 2-3
`
`(supplemental evidence is “offered solely to support admissibility of the originally
`
`filed evidence and to defeat a motion to exclude that evidence….”); R.J. Reynolds
`
`v. Fontem Holdings, Case IPR2016-01272, Paper 27 at 3 (“The intent of
`
`supplemental evidence is to alleviate the need for the Board to have to consider
`
`whether the initial evidence needs to be excluded….”). On its face, the only
`
`connection between Exhibit 1009 and Exhibit 1015 is that the same foreign
`
`document
`
`is
`
`translated. However, beyond
`
`this fact, Petitioner makes no
`
`representations regarding how Exhibit 1015 is related to Exhibit 1009 and provides
`
`no evidence that Exhibit 1009 was true and correct when it was filed. 37 C.F.R.
`
`§42.63(b). Accordingly, the deficiencies identified by the objections timely filed
`
`
`
`2
`
`
`
`
`
`by Patent Owner remain uncured, Exhibit 1015 has no effect on the admissibility
`
`of Exhibit 1009, and Exhibit 1015 is not properly before the Board as supplemental
`
`evidence in this proceeding. 37 C.F.R. §42.64(b)(2).
`
`Since Exhibit 1015 cannot be relied on to show the admissibility of Exhibit
`
`1009 and does not alleviate the Board’s need to address this Motion to Exclude, it
`
`appears, at best, to be late filed supplemental information under 37 C.F.R.
`
`§42.123(a). Supplemental
`
`information
`
`is “… additional
`
`information
`
`that
`
`potentially may be filed after institution of a trial and ‘must be relevant to a claim
`
`for which trial has been instituted’.” R.J. Reynolds, Paper 27 (Decision) at 3
`
`(emphasis in original)(citations omitted).
`
`When a party files a new declaration to cure failures under 37 C.F.R.
`
`§42.63(b), the Board considers these new declarations supplemental information.
`
`R.J. Reynolds, Case IPR2016-01272, Paper 27 at 3-4; and Paper 17 at 3-7
`
`(supplemental evidence is evidence used to authenticate the foreign patent while
`
`supplemental information is evidence that “cures the defect of the lack of an
`
`affidavit certifying the authenticity of the translation”); Taiwan Semiconductor v.
`
`DSS Tech. Mgmt., Inc., Case IPR2014-01030, Paper 11 at 3 (Board approving
`
`filing of declaration to cure deficiencies in originally filed declaration as
`
`supplemental information under Rule 42.123).
`
`
`
`3
`
`
`
`
`
`However, even new declarations filed as supplemental information provide a
`
`direct link to the evidence relied upon in the Petition. Id. In Exhibit 1015, that
`
`required link is missing. Mr. Loewus states under penalty of perjury that new
`
`Exhibit 1015 is a true and correct copy of DE 19542961, without referencing the
`
`authenticity of Exhibit 1009. Exhibit 1015 at 10. This is in contravention of
`
`previous Board rulings which state that the newly filed Declaration should “attest[]
`
`to the accuracy of the translation provided in” the originally filed exhibit. Nestle
`
`USA, Inc., Case IPR2014-01235, Paper 26 at 2 (waiving rules to allow filing of
`
`appropriate affidavit attesting to accuracy of the translation). Because the
`
`Declaration associated with Exhibit 1015 does not attest to the accuracy of the
`
`translation originally filed as Exhibit 1009, it is not clear that Exhibit 1015 should
`
`even be considered under supplemental information rules. Regardless, Petitioner
`
`has failed to argue, much less meet its burden, regarding the propriety of the late
`
`filed supplemental information.
`
`Instead of providing evidence to cure the deficiencies in Exhibit 1009,
`
`Petitioner argues that the Board should enter new Exhibit 1015. Opposition at 1-3.
`
`However, Exhibit 1015 fails to cure any deficiencies identified in Patent Owner’s
`
`Motion to Exclude because it does not relate to the admissibility of the original
`
`Exhibit 1009. Exhibit 1015 never addresses the declaration originally filed in
`
`Exhibit 1009 and provides no insight into the accuracy of the originally filed
`
`
`
`4
`
`
`
`
`
`translation. Accordingly, Patent Owner’s Motion to Exclude Exhibit 1009 should
`
`be granted, and Exhibit 1015 should not be considered as it is not appropriately
`
`before the Board in this proceeding.
`
`III. The Board Should Exclude Exhibits 1011 and 1012
`
`Petitioner effectively concedes that Exhibits 1011 and 1012 should be
`
`excluded, providing no actual argument that the exhibits are proper, and instead
`
`instructs the Board to regard this motion as “moot.” Opposition at 3-4. While it is
`
`uncontested that the Board can choose which exhibits to rely on in its Final
`
`Decision and dismiss a Motion to Exclude as moot, that is not a defense to using
`
`improper evidence as a basis for the Petition. Presumably, these documents are
`
`provided to increase the weight the Board gives to Dr. Atlas’ testimony, and to the
`
`extent they utilized for that purpose, excluding these documents impacts the Final
`
`Decision. While Petitioner states that these documents are “only used by Dr. Atlas
`
`in his Declaration as support for his statements regarding parameter settings and
`
`how they are set” (Opposition at 3-4), it remains true that the Board should not
`
`consider improper evidence in its Final Decision. To the extent that the Board
`
`relies on Dr. Atlas’ Declaration in its Final Decision, Exhibits 1011 and 1012
`
`should be excluded. Since the Petitioner did not provide any argument that
`
`Exhibits 1011 and 1012 are properly a part of this proceeding, the Board should
`
`grant this motion and exclude Exhibits 1011 and 1012.
`
`
`
`5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Henry A. Petri, Jr./
`Henry A. Petri Jr., Reg. No. 33,063
`James P. Murphy, Reg. No. 55,474
`Polsinelli, PC
`1000 Louisiana Street, 53rd Floor
`Houston, Texas 77002
`Tele: (713) 374-1631
`Fax: (713) 374-1601
`
`April 10, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`6
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing PATENT
`
`OWNER’S REPLY TO PETITIONER’S OPPOSITION TO PATENT OWNER’S
`
`MOTION TO EXCLUDE was served on April 10, 2018, via email directed to the
`
`following counsel of record for the Petitioner:
`
`Donald R. Steinberg
`Don.Steinberg@wilmerhale.com
`Yung-Hoon Ha
`Yung-Hoon.Ha@wilmerhale.com
`Haixia Lin
`Haixia.Lin@wilmerhale.com
`Christopher R. O’Brien
`Christopher.O’Brien@wilmerhale.com
`
`
`/Henry A. Petri, Jr./
`Henry A. Petri Jr., Reg. No. 33,063
`Polsinelli, PC
`1000 Louisiana Street, 53rd Floor
`Houston, Texas 77002
`Tele: (713) 374-1631
`Fax: (713) 374-1601
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`7
`
`